Skip to main content

Table 11 Diagnostic performance of follow-up AFP and amphiregulin in diagnosing tumor recurrence

From: Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment

Marker

AUC

Sensitivity (%)

Specificity (%)

SE

P

95% CI

Cutoff

Follow-up AFP

0.784

60

92

0.100

0.048*

0.588–0.980

≥ 1993.0

Follow-up amphiregulin

0.800

60

96

0.120

0.037*

0.464–1.000

≥ 29.7

  1. *Significant